# Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers

> **NCT02209051** · NA · COMPLETED · sponsor: **Integra LifeSciences Corporation** · enrollment: 29 (actual)

## Conditions studied

- Diabetic Foot Ulcers

## Interventions

- **OTHER:** AMNIOEXCEL
- **OTHER:** Standard of Care, Diabetic Foot Ulcers

## Key facts

- **NCT ID:** NCT02209051
- **Lead sponsor:** Integra LifeSciences Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2017-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02209051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02209051, "Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02209051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*